ATHE (alteritytherapeutics.com) Bozor qiymatining balans qiymatiga nisbati
Asosiy Parkinson kasalligiga qarshi dori vositasining 2-bosqichli sinovlari natijalari kutilayotgani va hozirgi vaqtda savdo hajmi yo'qligi Alterity Therapeutics (ATHE) aksiyalarining narx dinamikasiga ta'sir ko'rsatmoqda, u 1.33 darajasida turibdi. Kompaniya ATH434 molekulasining sinovlarini kengaytirish orqali neyrofarmatsevtika bozoridan ulush egallashni maqsad qilgan. Kompaniyaning narxlar grafigi ushbu jarayonlarni vizuallashtiradi. Biznes noyob miya patologiyalariga qarshi dori vositalarini ishlab chiqish va tor doiradagi tibbiy segmentlarga kirishga tayanadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ATHE_-_Alterity-Therapeutics_-_Capitalization-to-Book-Value-Ratio "ATHE Alterity Therapeutics Ltd Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Alterity Therapeutics (ATHE) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Alterity Therapeutics|ATHE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati alteritytherapeutics.com|ATHE - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Alterity Therapeutics Ltd|ATHE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Alterity Therapeutics
Kompaniyaning dastlabki tahlili:Alterity Therapeutics Ltd. - ATHE
Ushbu koeffitsient biznesning bozor qiymati va uning haqiqiy sof aktivlari o'rtasidagi farqni aks ettiradi. Balans hisoboti nisbatida bozor kapitalizatsiyasi dinamikasini tahlil qilish orqali investor kompaniyaning haddan tashqari qimmat baholanganligi yoki past baholanganligi darajasini aniqlaydi. Ushbu metrika birja talabini kapitalning balans qiymati bilan solishtirib, narx konsolidatsiyasi bosqichlarini aniqlaydi. Alterity Therapeutics (ATHE) uchun ushbu muvozanat robotlashtirilgan skrining tizimlarini joriy qilishda juda muhimdir. Neyrodegenerativ kasalliklar uchun dori vositalarini ishlab chiqishni avtomatlashtirish balans qiymatini bozor o'sishiga aylantirishi lozim.
Toʻgʻridan-toʻgʻri raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati BIIB|NBIX (neurocrine.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TRVI|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. (PRAX)|Bozor qiymatining balans qiymatiga nisbati Anavex AVXL|Kapitallashuvning sof aktivlarga nisbati CeriBell Corp (CBLL)|Bozor kapitallashuvining balans qiymatiga multiplikatori Prothena PRTA|ALEC (Alector Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati omeros.com OMER|Neurogene Inc (NGNE) - Balans qiymatiga nisbatan bozor qiymati|ACIU: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Voyager Corp (VYGR)|Kapitallashuvning sof aktivlarga nisbati Neumora Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori scilexholding.com SCLX|TVGN: Kapitallashuvning sof aktivlarga nisbati|ACOG - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Cognition Therapeutics, Inc. (CGTX)|Inhibikase Pharma (IKT) - Balans qiymatiga nisbatan bozor qiymati|SAVA - Kapitallashuvning sof aktivlarga nisbati|Assertio (ASRT) - Bozor kapitallashuvining balans qiymatiga multiplikatori|COYA - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati VistaGen Therapeutics Inc|Ovid Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ABOS (Acumen Pharmaceuticals, Inc)|Bozor qiymatining balans qiymatiga nisbati CervoMed Inc.|Balans qiymatiga nisbatan bozor qiymati Clene Inc CLNN|PepGen Corp - Bozor kapitallashuvining balans qiymatiga nisbati|JUNS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Relmada (RLMD)|Annovis Bio Corporation (ANVS) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati GRCE (Grace Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti fireflyneuro.com (AIFF)|Kapitallashuvning sof aktivlarga nisbati KLTO|Bozor kapitallashuvining balans qiymatiga nisbati neurosense-tx.com NRSN|Kapitallashuvning sof aktivlarga nisbati Reviva Pharmaceuticals Holdings (RVPH)|Bozor kapitallashuvining balans qiymatiga multiplikatori MetaVia Inc. MTVA|Bozor kapitallashuvining balans qiymatiga nisbati NRXS (NeurAxis, Inc.)|HSDT - Balans qiymatiga nisbatan bozor kapitallashuvi|PASG (passagebio.com) - Bozor kapitallashuvining balans qiymatiga nisbati|NEUP (Neuphoria Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|NERV: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Athira Pharma Corp|Bozor kapitallashuvining balans qiymatiga nisbati ADXN|Bozor kapitallashuvining balans qiymatiga nisbati alzamend.com ALZN|Kapitallashuvning sof aktivlarga nisbati Cyclerion Therapeutics, Inc. (CYCN)|Bozor kapitallashuvining balans qiymatiga multiplikatori Protagenic Therapeutics Inc. PTIX|Bozor kapitallashuvining balans qiymatiga nisbati Pasithea (KTTA)|CRGT - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ATXI|BCLI (brainstorm-cell.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics (CARA)|Kapitallashuvning balans qiymatiga nisbati Chromocell Therapeutics Corp|Eliem Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti intracellulartherapies.com ITCI|Kapitallashuvning sof aktivlarga nisbati LBPH (Longboard Pharmaceuticals)|marinuspharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NKGen Biotech (NKGN)|NRBO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati SAGE|Synaptogenix, Inc (SNPX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TRVN (Trevena, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VIGL|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. (WENA)|Bozor qiymatining balans qiymatiga nisbati Cerevel Therapeutics Inc CERE